Cytokeratin 12 Activators
Cytokeratin 12 (CK12) activators encompass a diverse array of chemicals that intricately modulate the expression and function of CK12, a member of the cytokeratin family crucial for maintaining the structural integrity of epithelial cells, particularly in the cornea. While direct activators may be limited, several compounds indirectly influence CK12 through intricate signaling pathways. One notable pathway involved in CK12 regulation is the TGF-β/Smad pathway. Inhibitors such as SB431542, LY2157299, and RepSox act as indirect activators by targeting TGF-β receptors, modulating Smad signaling, and potentially influencing CK12 expression. This pathway plays a pivotal role in epithelial-mesenchymal transition (EMT) and tissue fibrosis, processes that CK12 is intricately involved in. Another key signaling cascade is the PI3K-Akt pathway, where LY294002 indirectly activates CK12 by inhibiting PI3K, influencing CK12 expression and cellular processes associated with cell survival and differentiation. Additionally, the mTOR pathway, targeted by Rapamycin, and the JNK pathway, modulated by SP600125, provide alternative routes for indirect CK12 activation, impacting cellular growth, stress responses, and tissue repair.
Histone deacetylase (HDAC) inhibitors such as Trichostatin A indirectly influence CK12 expression by modulating chromatin structure. This epigenetic regulation contributes to the control of CK12 transcription and cellular processes related to cell differentiation and tissue homeostasis. Furthermore, small molecules like Y-27632, known ROCK inhibitors, indirectly impact CK12 by influencing actin cytoskeleton dynamics. This may affect CK12 organization and function, contributing to the regulation of cell morphology and migration. In conclusion, CK12 activators highlight the intricate interplay between chemical modulators and the complex signaling pathways involved in regulating CK12 expression and function. Whether through modulation of TGF-β signaling, PI3K-Akt pathway, or epigenetic regulation, these chemicals provide valuable insights into understanding CK12 activation and its implications in maintaining epithelial integrity and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 indirectly activates Cytokeratin 12 by inhibiting the TGF-β/Smad pathway. As a TGF-β receptor inhibitor, SB431542 prevents Smad2/3 phosphorylation and translocation, potentially influencing Cytokeratin 12 expression and cellular processes related to epithelial-mesenchymal transition (EMT) and cell differentiation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 indirectly activates Cytokeratin 12 by inhibiting ROCK (Rho-associated protein kinase). Inhibition of ROCK influences actin cytoskeleton dynamics, potentially impacting Cytokeratin 12 organization and function. This may contribute to the regulation of cell morphology and migration, affecting the overall cytoskeletal architecture. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
LY2157299 indirectly activates Cytokeratin 12 by inhibiting the TGF-β/Smad pathway. As a TGF-β receptor inhibitor, LY2157299 modulates TGF-β signaling, potentially influencing Cytokeratin 12 expression and cellular processes associated with tissue fibrosis and epithelial-mesenchymal transition (EMT). | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin indirectly activates Cytokeratin 12 by inhibiting the mTOR pathway. As an mTOR inhibitor, Rapamycin modulates protein synthesis and cell proliferation, potentially influencing Cytokeratin 12 expression and contributing to the regulation of cellular growth and differentiation in various tissues. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A indirectly activates Cytokeratin 12 by inhibiting histone deacetylases (HDACs). HDAC inhibition influences chromatin structure and gene expression, potentially impacting Cytokeratin 12 transcription and cellular processes related to cell differentiation and tissue homeostasis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 indirectly activates Cytokeratin 12 by inhibiting the PI3K-Akt pathway. As a PI3K inhibitor, LY294002 modulates Akt signaling, potentially influencing Cytokeratin 12 expression and cellular processes associated with cell survival, proliferation, and differentiation in various tissues. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $77.00 $153.00 $219.00 $663.00 $1248.00 $4382.00 $7850.00 | 8 | |
RepSox indirectly activates Cytokeratin 12 by inhibiting the TGF-β/Smad pathway. As a TGF-β receptor inhibitor, RepSox modulates TGF-β signaling, potentially influencing Cytokeratin 12 expression and cellular processes related to epithelial-mesenchymal transition (EMT) and tissue fibrosis. | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $327.00 $1377.00 | 2 | |
TGF-β1 Inhibitor (SB505124) indirectly activates Cytokeratin 12 by inhibiting the TGF-β/Smad pathway. As a TGF-β receptor inhibitor, SB505124 modulates TGF-β signaling, potentially influencing Cytokeratin 12 expression and cellular processes related to tissue fibrosis, wound healing, and epithelial-mesenchymal transition (EMT). | ||||||
Picrosid II | 39012-20-9 | sc-286677 sc-286677A | 20 mg 50 mg | $450.00 $902.00 | ||
Picroside II indirectly activates Cytokeratin 12 by modulating oxidative stress. As an antioxidant, Picroside II scavenges reactive oxygen species (ROS), potentially influencing Cytokeratin 12 expression and cellular processes associated with oxidative stress, inflammation, and tissue protection. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
Nordihydroguaiaretic Acid indirectly activates Cytokeratin 12 by modulating oxidative stress. As an antioxidant, Nordihydroguaiaretic Acid scavenges reactive oxygen species (ROS), potentially influencing Cytokeratin 12 expression and cellular processes associated with oxidative stress, inflammation, and tissue protection. | ||||||